We are live on ! Find out more
NA

Navellier & Associates Portfolio holdings

AUM $1.26B
1-Year Est. Return 95.39%
This Fund
S&P 500
This Quarter Est. Return
+13.08%
1 Year Est. Return
+95.39%
3 Year Est. Return
+360.87%
5 Year Est. Return
+519.82%
10 Year Est. Return
+3,025.56%
AUM
$556M
AUM Growth
+$3.81M
Cap. Flow
-$16.7M
Cap. Flow %
-3.01%
Top 10 Hldgs %
18.75%
Holding
334
New
59
Increased
88
Reduced
117
Closed
54

Top Buys

Rank Stock Value
1
TECH icon
Bio-Techne
TECH
+$7.5M
2
PYPL icon
PayPal
PYPL
+$7.37M
3
LFUS icon
Littelfuse
LFUS
+$6.9M
4
ENTG icon
Entegris
ENTG
+$6.86M
5
AMED
Amedisys
AMED
+$6.85M

Top Sells

Rank Stock Value
1
VRSK icon
Verisk Analytics
VRSK
+$12.2M
2
PAYC icon
Paycom
PAYC
+$8.46M
3
ZTS icon
Zoetis
ZTS
+$7.77M
4
V icon
Visa
V
+$7.46M
5
BALL icon
Ball Corp
BALL
+$7.15M

Sector Composition

Rank Sector Weight
1 Technology 33.34%
2 Healthcare 14.27%
3 Consumer Discretionary 11.88%
4 Industrials 8.92%
5 Consumer Staples 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRI icon
251
Darden Restaurants
DRI
$23.8B
$258K 0.05%
1,818
-13
-0.7% -$1.71K
KRNT icon
252
Kornit Digital
KRNT
$781M
$258K 0.05%
2,605
+169
+7% +$16.7K
CRMT icon
253
America's Car Mart
CRMT
$28.4M
$254K 0.05%
+1,669
New +$227K
CRSP icon
254
CRISPR Therapeutics
CRSP
$5.07B
$247K 0.04%
2,026
ABR icon
255
Arbor Realty Trust
ABR
$965M
$244K 0.04%
15,369
-108,097
-88% -$1.67M
GLW icon
256
Corning
GLW
$135B
$244K 0.04%
5,600
-400
-7% -$15.4K
MLAB icon
257
Mesa Laboratories
MLAB
$574M
$240K 0.04%
985
QRVO icon
258
Qorvo
QRVO
$8.4B
$240K 0.04%
1,312
-8
-0.6% -$1.41K
SPTN
259
DELISTED
SpartanNash
SPTN
$240K 0.04%
12,216
+1,107
+10% +$21K
PG icon
260
Procter & Gamble
PG
$341B
$239K 0.04%
1,763
-100
-5% -$13K
MLI icon
261
Mueller Industries
MLI
$15.3B
$235K 0.04%
+22,752
New +$224K
VRSN icon
262
VeriSign
VRSN
$26.5B
$232K 0.04%
1,167
-6
-0.5% -$1.18K
ALK icon
263
Alaska Air
ALK
$5.81B
$230K 0.04%
+3,324
New +$200K
COO icon
264
Cooper Companies
COO
$14.6B
$230K 0.04%
2,392
-16
-0.7% -$1.52K
NOC icon
265
Northrop Grumman
NOC
$79.2B
$230K 0.04%
711
+3
+0.4% +$904
BFAM icon
266
Bright Horizons
BFAM
$3.97B
$227K 0.04%
1,325
-7
-0.5% -$1.15K
SGC icon
267
Superior Group of Companies
SGC
$221M
$227K 0.04%
+8,919
New +$222K
HSY icon
268
Hershey
HSY
$36.1B
$226K 0.04%
1,431
+8
+0.6% +$1.21K
NVTA
269
DELISTED
Invitae Corporation
NVTA
$224K 0.04%
5,852
-33
-0.6% -$1.5K
TAL icon
270
TAL Education Group
TAL
$6.71B
$221K 0.04%
4,110
YUMC icon
271
Yum China
YUMC
$16.3B
$211K 0.04%
3,569
+7
+0.2% +$418
KMX icon
272
CarMax
KMX
$8.04B
$210K 0.04%
+1,586
New +$193K
PERI icon
273
Perion Network
PERI
$378M
$209K 0.04%
11,655
RBNC
274
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$206K 0.04%
+7,165
New +$165K
ACCS
275
ACCESS Newswire
ACCS
$26.7M
$204K 0.04%
+9,319
New +$205K

Similar funds

Navellier & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, Navellier & Associates held 334 positions worth $556M, up 0.69% from $552M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Navellier & Associates withdrew a net $16.7M in Q1 2021, closing 54 positions and reducing 117 holdings. Its most notable exit was Verisk Analytics, an estimated $12.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Navellier & Associates opened a new position in Bio-Techne worth $7.85M.

  • Navellier & Associates's largest Q1 2021 buy was Bio-Techne: 82,224 shares worth $7.85M.
  • Navellier & Associates added most to PayPal in Q1 2021, an estimated $7.37M increase.
  • Navellier & Associates's biggest Q1 2021 reduction was Paycom, cutting an estimated $8.46M.
  • Navellier & Associates fully exited Verisk Analytics in Q1 2021, selling an estimated $12.2M.
  • Navellier & Associates's ten largest holdings make up 19% of its $556M portfolio in Q1 2021.
  • Navellier & Associates opened 59 new positions and closed 54 in Q1 2021.
  • Navellier & Associates's portfolio value rose 0.69% quarter-over-quarter to $556M.

Based on Navellier & Associates's 13F filing for Q1 2021, filed 12 May 2021.